# Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer

> **NCT04483076** · PHASE3 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 524 (estimated)

## Conditions studied

- Gastric Cancer
- Chemotherapy Effect

## Interventions

- **DRUG:** Chemotherapy drug
- **PROCEDURE:** Gastrectomy
- **PROCEDURE:** Laparoscopic exploration

## Key facts

- **NCT ID:** NCT04483076
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-13
- **Primary completion:** 2022-12
- **Final completion:** 2028-12
- **Target enrollment:** 524 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04483076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04483076, "Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04483076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*